Several hematological markers were reported to suggest a poor prognosis for lung cancer after bone metastasis including hypoalbuminemia, increased ALP and tumor-markers, and systemic inflammation, as evidenced by hyperleucemia, neutrophilia or high C-reactive protein (CRP) level (6, 7, 20–23). The gene discussed is CRP; the disease is neoplasm.